# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-17-012273
Filing Date
2017-12-08
Accepted
2017-12-08 17:17:19
Documents
29
Period of Report
2017-12-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K - INVESTOR PRESENTATION DEC. 2017 | a8k-investorpresentationde.htm | 8-K | 34416
2 | EXHIBIT 99.1 INVESTOR PRESENTATION | cpixinvestorpresentation.htm | EX-99.1 | 21074
3 |  | cpixinvestorpresentation001.jpg | GRAPHIC | 92033
4 |  | cpixinvestorpresentation002.jpg | GRAPHIC | 154341
5 |  | cpixinvestorpresentation003.jpg | GRAPHIC | 100600
6 |  | cpixinvestorpresentation004.jpg | GRAPHIC | 95154
7 |  | cpixinvestorpresentation005.jpg | GRAPHIC | 106779
8 |  | cpixinvestorpresentation006.jpg | GRAPHIC | 132350
9 |  | cpixinvestorpresentation007.jpg | GRAPHIC | 29757
10 |  | cpixinvestorpresentation008.jpg | GRAPHIC | 95419
11 |  | cpixinvestorpresentation009.jpg | GRAPHIC | 117430
12 |  | cpixinvestorpresentation010.jpg | GRAPHIC | 91248
13 |  | cpixinvestorpresentation011.jpg | GRAPHIC | 97810
14 |  | cpixinvestorpresentation012.jpg | GRAPHIC | 137127
15 |  | cpixinvestorpresentation013.jpg | GRAPHIC | 116335
16 |  | cpixinvestorpresentation014.jpg | GRAPHIC | 119870
17 |  | cpixinvestorpresentation015.jpg | GRAPHIC | 100693
18 |  | cpixinvestorpresentation016.jpg | GRAPHIC | 81481
19 |  | cpixinvestorpresentation017.jpg | GRAPHIC | 108987
20 |  | cpixinvestorpresentation018.jpg | GRAPHIC | 91091
21 |  | cpixinvestorpresentation019.jpg | GRAPHIC | 62424
22 |  | cpixinvestorpresentation020.jpg | GRAPHIC | 102611
23 |  | cpixinvestorpresentation021.jpg | GRAPHIC | 92033
24 |  | cpixinvestorpresentation022.jpg | GRAPHIC | 47949
25 |  | cpixinvestorpresentation023.jpg | GRAPHIC | 92919
26 |  | cpixinvestorpresentation024.jpg | GRAPHIC | 94591
27 |  | cpixinvestorpresentation025.jpg | GRAPHIC | 148919
28 |  | cpixinvestorpresentation026.jpg | GRAPHIC | 120591
29 |  | cpixinvestorpresentation027.jpg | GRAPHIC | 141396
| Complete submission text file | 0001628280-17-012273.txt |  | 3862424

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 171247822
SIC: 2834 Pharmaceutical Preparations